The promise of help with weight loss is always alluring. But what if that solution comes with a few hidden risks?In South Africa, where obesity rates...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity,...

GLP1-based obesity medicines, such as Ozempic and Wegovy, have surged in popularity and become the subject of intense public debate.

MONDAY, Feb. 10, 2025 -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether...

Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight...

High blood pressure, also called hypertension, is a common health problem that can lead to serious issues like heart attacks, strokes, and kidney...

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity. The dramatic effects of these drugs,...

WEDNESDAY, Feb. 5, 2025 -- “Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease...

Losing and regaining weight repeatedly—a pattern known as yo-yo dieting or body-weight cycling—can significantly increase the risk of kidney...

Losing weight can be a powerful way to improve health, especially for people with diabetes. It can help control blood sugar, reduce the need for...